|
Price: $235.6700
$-0.56 
-0.237%
|
| Day's High:
| $237.74
| Week Perf:
| -2.35 %
|
| Day's Low: |
$ 234.53 |
30 Day Perf: |
-6.68 % |
| Volume (M): |
666 |
52 Wk High: |
$ 252.79 |
| Volume (M$): |
$ 156,909 |
52 Wk Avg: |
$226.06 |
| Open: |
$236.96 |
52 Wk Low: |
$200.98 |
|
|
| Market Capitalization (Millions $) |
23,363 |
| Shares
Outstanding (Millions) |
99 |
| Employees |
18,000 |
| Revenues (TTM) (Millions $) |
5,460 |
| Net Income (TTM) (Millions $) |
616 |
| Cash Flow (TTM) (Millions $) |
-35 |
| Capital Exp. (TTM) (Millions $) |
370 |
Steris Plc
Steris Plc is a prominent global leader in the provision of sterilization and infection prevention solutions across various industries, including healthcare, life sciences, industrial manufacturing, and pharmaceuticals. Founded in 1985 and headquartered in Dublin, Ireland, the company has established itself as a crucial player in ensuring safety and efficacy in environments that require stringent infection control measures.
Product Offerings
Steris Plc offers an extensive range of products designed to meet the diverse needs of its customers:
- Sterilizers: These are essential for the sterilization of surgical instruments, medical devices, and laboratory equipment, ensuring that they are free from all microorganisms.
- Washer-Disinfectors: Designed to clean and disinfect medical equipment and instruments, these devices are critical in healthcare settings to maintain hygiene standards.
- Endoscope Cleaning and Disinfection Systems: These systems play a vital role in ensuring that endoscopes are effectively cleaned and sterilized between uses to avert cross-contamination.
- Biological Indicators: Used to monitor the effectiveness of sterilization processes, these indicators help in validating that the sterilization parameters have been met.
Services
Beyond product offerings, Steris Plc provides a range of services that support its customers:
- Equipment Maintenance: This includes routine maintenance and repairs to ensure that sterilization equipment operates efficiently and effectively.
- Technical Support: Steris Plc offers expert technical assistance to address any operational challenges that customers may face with their sterilization systems.
- Training Services: To ensure optimal performance and compliance, the company provides training for healthcare and laboratory personnel on the proper use of its products and systems.
Market Segments
The largest market for Steris Plc is the healthcare sector, where the company supplies products and services to healthcare providers. These solutions are designed to protect patients from healthcare-associated infections (HAIs). Steris Plcs offerings help maintain sterile environments in operating rooms, patient care areas, and other clinical settings.
In addition to healthcare, Steris Plcs life sciences segment caters to biopharmaceutical manufacturing companies, providing sterilization and infection prevention solutions critical for preventing contamination and ensuring the quality of biopharmaceutical products.
The company's industrial segment addresses the needs of manufacturing processes that require sterilization and contamination control, particularly in settings such as research laboratories and biotechnology industries.
Commitment to Sustainability and Corporate Responsibility
Steris Plc is dedicated to sustainability and corporate responsibility. The company actively seeks to minimize its environmental footprint through various initiatives in its operations, products, and supply chain practices. This commitment extends to promoting diversity and inclusion within its workforce, aiming to create a supportive and dynamic working environment.
Overall Impact
Through its comprehensive range of infection prevention and sterilization solutions, Steris Plc plays a vital role in improving patient safety, ensuring product integrity, and creating cleaner environments across multiple industries. The company's focus on innovation and customer satisfaction has solidified its position as a trusted leader in the sterilization and infection prevention market.
Company Address: 70 Sir John Rogerson s Quay, Dublin 2, 0
Company Phone Number: 232 2000 Stock Exchange / Ticker: NYSE STE
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Dividend
Published Tue, Jan 28 2025 10:00 PM UTC
STERIS Strengthens Shareholder Confidence with New Dividend Declaration Amid Growth AspirationsIn a notable commitment to enhancing shareholder value, STERIS plc (NYSE: STE) declared an interim quarterly dividend of $0.57 per share on January 28, 2025. The dividend will be paid out on March 21, 2025, to all shareholders on record as of the close of business on February 20, ...
|
| Dividend
Published Wed, Oct 30 2024 8:30 PM UTC
STERIS plc Announces Quarterly Dividend, Reaffirming Shareholder Commitment Amid Strategic Growth Overview of Dividend AnnouncementDUBLIN, IRELAND, Oct. 30, 2024 STERIS plc (NYSE: STE), a global leader in infection prevention, announced today a quarterly interim dividend of $0.57 per share. This commitment continues the Company s tradition of returning capital to sharehold...
|
| Dividend
Published Wed, Jul 31 2024 8:30 PM UTC
STERIS Increases Dividend Amidst Growing Earnings: Promises Steady Returns for Shareholders
In a recent announcement that signifies stability and growth, STERIS plc (NYSE: STE) declared a quarterly interim dividend of $0.57 per share, marking a $0.05 increase from the previous payout. This decision, unveiled in a press release dated July 31, 2024, highlights the company ...
|
| Merger and Acquisition
Published Thu, Apr 11 2024 10:58 AM UTC
DUBLIN, IRELAND, April 11, 2024 - STERIS plc (NYSE: STE) has recently announced its plan to sell its Dental segment to Peak Rock Capital, a reputable mid-market private investment firm, for a total consideration of $787.5 million. This divestiture aligns with STERIS strategy to strengthen its focus on providing infection prevention, decontamination, surgical, and ...
|
| Steris Plc
Steris Plc Reports Strong Financial Results in Q3 2024
Steris Plc, a leading company in the Medical Equipment & Supplies industry, has announced its financial results for the third quarter of 2024. The company reported revenue of $1.40 billion and earnings per share of $1.42. These results indicate a significant year-on-year growth, with revenue increasing by 14.774% and net profit per share growing by 14.52%.
In comparison to its industry peers, Steris Plc's top-line growth outperformed most other companies in the Medical Equipment & Supplies sector during the same reporting period. While the top-line for the two third-party companies in the sector advanced by only 3.13% from the previous year, Steris Plc experienced a much higher growth rate.
|
| Per Share |
Current |
| Earnings (TTM) |
6.2 $ |
| Revenues (TTM) |
55.07 $
|
| Cash Flow (TTM) |
- |
| Cash |
-
|
| Book Value |
66.73 $
|
| Dividend (TTM) |
2.23 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
6.2 $
|
| Revenues (TTM) |
55.07 $ |
| Cash Flow (TTM) |
- |
| Cash |
-
|
| Book Value |
66.73 $ |
| Dividend (TTM) |
2.23 $ |
|
|
| |
| IRELAND |
|
 1.76 % |
of total Revenue |
| UNITED STATES |
|
73.15 % |
of total Revenue |
| Other foreign locations |
|
25.09 % |
of total Revenue |
| Healthcare |
|
71.21 % |
of total Revenue |
| Healthcare Capital equipment revenues |
|
18.59 % |
of total Revenue |
| Healthcare Consumable revenues |
|
26.14 % |
of total Revenue |
| Healthcare Sales Revenue Services Net |
|
26.49 % |
of total Revenue |
| Applied Sterilization Technologies |
|
18.83 % |
of total Revenue |
| Applied Sterilization Technologies Capital equipment revenues |
|
0.37 % |
of total Revenue |
| Applied Sterilization Technologies Sales Revenue Services Net |
|
18.47 % |
of total Revenue |
| Life Science Member |
|
9.95 % |
of total Revenue |
| Life Science Member Capital equipment revenues |
|
2.27 % |
of total Revenue |
| Life Science Member Consumable revenues |
|
5.01 % |
of total Revenue |
| Life Science Member Sales Revenue Services Net |
|
2.67 % |
of total Revenue |
|
|
